New funding for regenerative small molecule development
Scientists from University of Texas Southwestern and Case Western Reserve University have raised US$5.9 million to develop 15-PGDH inhibitors into human therapeutics.
Please sign in or register for FREE to view this content
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.